123 related articles for article (PubMed ID: 21945253)
1. Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles.
Zhao K; Shi X; Zhao Y; Wei H; Sun Q; Huang T; Zhang X; Wang Y
Vaccine; 2011 Nov; 29(47):8549-56. PubMed ID: 21945253
[TBL] [Abstract][Full Text] [Related]
2. Preparation and immunological effectiveness of a Swine influenza DNA vaccine encapsulated in PLGA microspheres.
Zhao K; Li GX; Jin YY; Wei HX; Sun QS; Huang TT; Wang YF; Tong GZ
J Microencapsul; 2010; 27(2):178-86. PubMed ID: 20121488
[TBL] [Abstract][Full Text] [Related]
3. Immunization with a low dose of hemagglutinin-encoding plasmid protects against 2009 H1N1 pandemic influenza virus in mice.
Fang J; Chen Z; Liu X; Li H; Wang J; Shen X; Chen W; Liu Y; Wang Y; Zhao P; Qi Z
J Virol Methods; 2011 May; 173(2):314-9. PubMed ID: 21392537
[TBL] [Abstract][Full Text] [Related]
4. Conjugating influenza a (H1N1) antigen to n-trimethylaminoethylmethacrylate chitosan nanoparticles improves the immunogenicity of the antigen after nasal administration.
Liu Q; Zheng X; Zhang C; Shao X; Zhang X; Zhang Q; Jiang X
J Med Virol; 2015 Nov; 87(11):1807-15. PubMed ID: 25959372
[TBL] [Abstract][Full Text] [Related]
5. Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant.
Sui Z; Chen Q; Wu R; Zhang H; Zheng M; Wang H; Chen Z
Arch Virol; 2010 Apr; 155(4):535-44. PubMed ID: 20195654
[TBL] [Abstract][Full Text] [Related]
6. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.
Amidi M; Romeijn SG; Verhoef JC; Junginger HE; Bungener L; Huckriede A; Crommelin DJ; Jiskoot W
Vaccine; 2007 Jan; 25(1):144-53. PubMed ID: 16973248
[TBL] [Abstract][Full Text] [Related]
7. Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant.
Sui Z; Chen Q; Fang F; Zheng M; Chen Z
Vaccine; 2010 Nov; 28(48):7690-8. PubMed ID: 20870054
[TBL] [Abstract][Full Text] [Related]
8. Codon-optimization of the hemagglutinin gene from the novel swine origin H1N1 influenza virus has differential effects on CD4(+) T-cell responses and immune effector mechanisms following DNA electroporation in mice.
Tenbusch M; Grunwald T; Niezold T; Storcksdieck Genannt Bonsmann M; Hannaman D; Norley S; Uberla K
Vaccine; 2010 Apr; 28(19):3273-7. PubMed ID: 20206668
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of seasonal pandemic influenza hemagglutinin DNA vaccines delivered by electroporation against a seasonal H1N1 virus challenge in mice.
Tan L; Lu H; Zhang D; Wang K; Tian M; Liu C; Liu Y; Hu B; Jin N
Sci China Life Sci; 2011 Apr; 54(4):293-9. PubMed ID: 21416231
[TBL] [Abstract][Full Text] [Related]
10. Enhanced immune response and protective efficacy of a Treponema pallidum Tp92 DNA vaccine vectored by chitosan nanoparticles and adjuvanted with IL-2.
Zhao F; Wu Y; Zhang X; Yu J; Gu W; Liu S; Zeng T; Zhang Y; Wang S
Hum Vaccin; 2011 Oct; 7(10):1083-9. PubMed ID: 21941092
[TBL] [Abstract][Full Text] [Related]
11. Intranasal chitosan-DNA vaccines that protect across influenza virus subtypes.
Sawaengsak C; Mori Y; Yamanishi K; Srimanote P; Chaicumpa W; Mitrevej A; Sinchaipanid N
Int J Pharm; 2014 Oct; 473(1-2):113-25. PubMed ID: 24998507
[TBL] [Abstract][Full Text] [Related]
12. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
Khatri K; Goyal AK; Gupta PN; Mishra N; Vyas SP
Int J Pharm; 2008 Apr; 354(1-2):235-41. PubMed ID: 18182259
[TBL] [Abstract][Full Text] [Related]
13. A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice.
Joseph A; Itskovitz-Cooper N; Samira S; Flasterstein O; Eliyahu H; Simberg D; Goldwaser I; Barenholz Y; Kedar E
Vaccine; 2006 May; 24(18):3990-4006. PubMed ID: 16516356
[TBL] [Abstract][Full Text] [Related]
14. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
[TBL] [Abstract][Full Text] [Related]
15. The virus-induced signaling adaptor molecule enhances DNA-raised immune protection against H5N1 influenza virus infection in mice.
Luo M; Qu X; Pan R; Zhu D; Zhang Y; Wu J; Pan Z
Vaccine; 2011 Mar; 29(14):2561-7. PubMed ID: 21303708
[TBL] [Abstract][Full Text] [Related]
16. Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies.
Lo CY; Wu Z; Misplon JA; Price GE; Pappas C; Kong WP; Tumpey TM; Epstein SL
Vaccine; 2008 Apr; 26(17):2062-72. PubMed ID: 18378366
[TBL] [Abstract][Full Text] [Related]
17. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
Park KS; Seo YB; Lee JY; Im SJ; Seo SH; Song MS; Choi YK; Sung YC
Vaccine; 2011 Jul; 29(33):5481-7. PubMed ID: 21664216
[TBL] [Abstract][Full Text] [Related]
18. Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study.
Zheng F; Shi XW; Yang GF; Gong LL; Yuan HY; Cui YJ; Wang Y; Du YM; Li Y
Life Sci; 2007 Jan; 80(4):388-96. PubMed ID: 17074366
[TBL] [Abstract][Full Text] [Related]
19. Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device.
Broderick KE; Shen X; Soderholm J; Lin F; McCoy J; Khan AS; Yan J; Morrow MP; Patel A; Kobinger GP; Kemmerrer S; Weiner DB; Sardesai NY
Gene Ther; 2011 Mar; 18(3):258-65. PubMed ID: 20962869
[TBL] [Abstract][Full Text] [Related]
20. Heterosubtypic immunity to influenza mediated by liposome adjuvanted H5N1 recombinant protein vaccines.
Thueng-in K; Maneewatch S; Srimanote P; Songserm T; Tapchaisri P; Sookrung N; Tongtawe P; Channarong S; Chaicumpa W
Vaccine; 2010 Sep; 28(41):6765-77. PubMed ID: 20688037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
